Exploiting mucosal surfaces for the development of mucosal vaccines

被引:27
|
作者
Meeusen, Els N. [1 ]
机构
[1] Monash Univ, Biotechnol Res Labs, Sch Biomed Sci, Melbourne, Vic 3800, Australia
关键词
Mucosal vaccines; Mucosal adjuvants; Tissue-specific immunity; Lymphocyte migration; IMMUNE-RESPONSES; DENDRITIC CELLS; GASTROINTESTINAL NEMATODE; DUCT CANNULATION; AFFERENT LYMPH; T-CELLS; B-CELLS; GUT; IMMUNIZATION; INDUCTION;
D O I
10.1016/j.vaccine.2011.09.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mucosal immunity covers a variety of mucosal surfaces susceptible to different pathogens. This review highlights the diversity of mucosal tissues and the unique microenvironments in which an immune response is generated. It argues that tissue-specific factors present throughout mucosal tissues and lymph nodes determine the differentiation into IgA-producing B cells, which in turn determines their migration patterns. Mucosal immunity can therefore be induced when antigen is delivered at any mucosal tissue without the need for specific 'mucosal adjuvants' or targeting to specialised lymphoid structures. Non-oral vaccination strategies directed at alternative and more accessible mucosal tissue sites, may provide new avenues for both mucosal and systemic immunization, and will be greatly facilitated by the use of large animal models. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8506 / 8511
页数:6
相关论文
共 50 条
  • [1] Exploiting Mucosal Immunity for Antiviral Vaccines
    Iwasaki, Akiko
    ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 : 575 - 608
  • [2] Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants
    Anggraeni, Rahmi
    Ana, Ika Dewi
    Wihadmadyatami, Nevi
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2022, 11 (03) : 235 - 248
  • [3] Adenoviruses as vectors for delivering vaccines to mucosal surfaces
    Babiuk, LA
    Tikoo, SK
    JOURNAL OF BIOTECHNOLOGY, 2000, 83 (1-2) : 105 - 113
  • [4] MUCOSAL SURFACES - ALTERNATIVE TARGET SITE FOR VACCINES
    GORDON, J
    ASM NEWS, 1995, 61 (08): : 393 - 393
  • [5] The role of adjuvants in the development of mucosal vaccines
    Vajdy, M
    Singh, M
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (07) : 953 - 965
  • [6] Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles
    Srivastava, Atul
    Gowda, Devegowda Vishakante
    Madhunapantula, SubbaRao V.
    Shinde, Chetan G.
    Iyer, Meenakshi
    APMIS, 2015, 123 (04) : 275 - 288
  • [7] Optimism over vaccines administered via mucosal surfaces
    Levine, MM
    Dougan, G
    LANCET, 1998, 351 (9113): : 1375 - 1376
  • [8] Challenges and opportunities in the development of mucosal mRNA vaccines
    Kirtane, Ameya R.
    Tang, Chaoyang
    Freitas, Dylan
    Bernstock, Joshua D.
    Traverso, Giovanni
    CURRENT OPINION IN IMMUNOLOGY, 2023, 85
  • [9] Perspectives on mucosal vaccines: Is mucosal tolerance a barrier?
    Mestecky, Jiri
    Russell, Michael W.
    Elson, Charles O.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (09): : 5633 - 5638
  • [10] Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines
    Belyakov, IM
    Berzofsky, JA
    IMMUNITY, 2004, 20 (03) : 247 - 253